StonvexLoading…
StonvexStonvexStonvexCore line items from AMKR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $6.71B | $6.32B | $6.50B | $7.09B |
Operating Income | $467.38M | $438.45M | $470.29M | $897.19M |
Net Income | $373.89M | $354.01M | $359.81M | $765.82M |
EPS (Diluted) | $1.50 | $1.43 | $1.46 | $3.11 |
Total Assets | $8.14B | $6.94B | $6.77B | $6.82B |
Total Liabilities | $3.63B | $2.76B | $2.78B | $3.12B |
Cash & Equivalents | $1.38B | $1.13B | $1.12B | $959.07M |
Free Cash Flow OCF − CapEx | $190.99M | $345.07M | $520.55M | $190.46M |
Shares Outstanding | 247.30M | 246.68M | 245.89M | 245.09M |